MedAdvisor Ltd
MDR
Company Profile
Business description
MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has three reporting segments: ANZ Operations, U.S. Operations and UK Operations. The company derives majority of its revenues from U.S. Operations.
Contact
971 Burke Road
Level 2
CamberwellVIC3124
AUST: +61 390953036
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Stellar growth from ASX retailer but markets still too optimistic
This Australian success story looks set to face profit margin compression from the scariest of competitors.
stocks
How to focus on the right things this reporting season
For individual investors, it is important to frame earnings season revelations in a long-term way.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,150.30 | 32.70 | 0.36% |
| CAC 40 | 7,715.71 | 17.19 | 0.22% |
| DAX 40 | 23,982.88 | 98.46 | -0.41% |
| Dow JONES (US) | 44,190.95 | 215.86 | 0.49% |
| FTSE 100 | 9,130.82 | 1.11 | 0.01% |
| HKSE | 24,969.68 | 62.87 | 0.25% |
| NASDAQ | 21,508.84 | 123.44 | 0.58% |
| Nikkei 225 | 42,718.17 | 897.69 | 2.15% |
| NZX 50 Index | 12,759.68 | 152.18 | -1.18% |
| S&P 500 | 6,404.88 | 31.43 | 0.49% |
| S&P/ASX 200 | 8,880.80 | 36.00 | 0.41% |
| SSE Composite Index | 3,665.92 | 18.37 | 0.50% |